热性心室炎的治疗方法是用回心室外心室排水来治疗
1Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China; Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
World neurosurgery
|August 2, 2025
概括
后耳外腔室排水 (RaEVD) 提供了一种安全有效的方法来治疗严重的内感染,如发热性心室炎. 这种新的技术显示了改善排水持续时间和导管通透性的潜力.
科学领域:
- 神经外科 神经外科
- 传染性疾病 传染性疾病
- 医疗设备创新 医疗设备创新
背景情况:
- 发烧性心室炎 (PV) 和心室内 (IVE) 是关键的内感染,具有显著的发病率和死亡率.
- 目前对PV和IVE的治疗选择,包括神经内镜洗和各种外部心室排水 (EVD) 方法,都有局限性.
- 背耳外腔室排水 (RaEVD) 技术是为了解决这些局限性而开发的.
研究的目的:
- 评估新的RaEVD技术的临床有效性和安全性.
- 评估RaEVD在治疗发热性心室炎和心室内静脉瘤患者中的实用性.
- 将RaEVD的结果与这些严重感染的现有治疗方法进行比较.
主要方法:
- 追溯性,单中心研究,涉及7名接受9次RaEVD手术的患者.
- 在局部麻醉下使用10-Fr EVD导管进行RaEVD,该导管具有后耳道出口部位.
- 对临床结果,排水时间,并发症和修改的兰金度量表 (mRS) 评分的分析.
主要成果:
- 平均排水时间为23天,没有报告了与导管相关的感染,CSF泄漏或脱.
- 中位数mRS得分显著改善,从手术前的4到手术后的1.
- 在57.1%的患者中获得了有利的结局 (mRS 0-1);死亡率为28.6%.
结论:
- RaEVD为管理光伏和IVE提供了一种安全有效的方法.
- 潜在的优势包括延长排水时间,保持导管通透性和程序简单性.
- 需要对更大患者队伍进行进一步的研究和延长的随访,以确认疗效.
相关概念视频
Acute Pyelonephritis II: Diagnostic Studies and Management
40
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
40
Acute Pyelonephritis I: Introduction
50
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
50
Tonsillitis II: Management
177
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
177
Endocarditis III: Medical Management
17
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
17
Pneumonia IV: Management
447
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
447
Endocarditis IV: Nursing Management
30
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
30


